Cargando…
Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait
Autores principales: | Sienaert, Pascal, Lambrichts, Simon, Popleu, Leen, Van Gerven, Elke, Buggenhout, Satya, Bouckaert, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Geriatric Psychiatry. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195425/ https://www.ncbi.nlm.nih.gov/pubmed/32345550 http://dx.doi.org/10.1016/j.jagp.2020.04.013 |
Ejemplares similares
-
Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?
por: Lambrichts, S., et al.
Publicado: (2022) -
Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome
por: van Zutphen, Elisabeth Maria, et al.
Publicado: (2019) -
The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
por: Loef, Dore, et al.
Publicado: (2021) -
Development of temporal lobe epilepsy during maintenance electroconvulsive therapy: A case of human kindling?
por: Schotte, Caroline, et al.
Publicado: (2019) -
Biophysical mechanisms of electroconvulsive therapy-induced volume expansion in the medial temporal lobe: A longitudinal in vivo human imaging study
por: Takamiya, Akihiro, et al.
Publicado: (2021)